Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Xylocaine — XYLOCAINE 5% W/ GLUCOSE 7.5%
Application NDA010496 (NDA)
Xylocaine — XYLOCAINE 4% PRESERVATIVE FREE
Application NDA010417 (NDA)
Xylocaine — XYLOCAINE DENTAL
Application NDA021380 (NDA)
Xylocaine — XYLOCAINE 1.5% W/ DEXTROSE 7.5%
Application NDA016297 (NDA)
Xylocaine — XYLOCAINE
Application NDA008816 (NDA)
Xylocaine — XYLOCAINE
Application NDA008048 (NDA)
Xylocaine — XYLOCAINE VISCOUS
Application NDA009470 (NDA)
Xylocaine — XYLOCAINE
Application NDA014127 (NDA)
Xylocaine — XYLOCAINE
Application NDA013077 (NDA)
Xylocaine — XYLOCAINE
Application NDA006488 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA018967 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA018954 (NDA)
Xylocaine — XYLOCAINE PRESERVATIVE FREE
Application NDA016801 (NDA)
Xylocaine — LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
Application NDA019830 (NDA)
Xylocaine — DENTIPATCH
Application NDA020575 (NDA)
Xylocaine — LIDODERM
Application NDA020612 (NDA)
Xylocaine — ZINGO
Application NDA022114 (NDA)
Xylocaine — AKTEN
Application NDA022221 (NDA)
Xylocaine — ZTLIDO
Application NDA207962 (NDA)
Xylocaine — BONDLIDO
Application NDA215029 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)